Stay updated on Pembrolizumab Maintenance in sNSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Maintenance in sNSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows Revision: v3.5.4, replacing v3.5.3, signaling a new release of the site interface. This appears to be a maintenance update with no changes to the trial information presented on the page.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page’s revision indicator was updated from **v3.5.2** to **v3.5.3**. This reflects an underlying site/version change rather than a change to the trial’s content.SummaryDifference0.1%

- Check42 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page revision label was updated from v3.4.3 to v3.5.0. This change does not affect study details or core page behavior.SummaryDifference0.1%

- Check78 days agoChange DetectedThe page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check85 days agoChange DetectedNo additions or deletions were detected; the page content appears unchanged.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Maintenance in sNSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Maintenance in sNSCLC Clinical Trial page.